Insead

GlobalSource Partners is a trusted resource for savvy investors and business leaders seeking accurate insights into emerging markets. Their network of esteemed analysts, including former finance ministers and central bank heads, offers candid and unfiltered economic analyses to inform critical investment and corporate decisions. With a focus on asset management, corporate budgeting, and private equity, GlobalSource Partners provides unparalleled expertise in navigating the complexities of economic policies and market volatility. Their analytical reports and real-time updates serve to enhance clients' understanding and ability to capitalize on emerging market opportunities. Generated from the website

New York Mortgage Resources is a reputable financial institution based in New York, NY, specializing in mortgage services for individuals and businesses. With a focus on providing tailored solutions to meet the unique needs of each client, they offer a range of mortgage products and expert advice. Committed to transparency and customer satisfaction, New York Mortgage Resources strives to simplify the mortgage process and help clients achieve their homeownership goals. Their team of experienced professionals is dedicated to guiding clients through every step of the mortgage application and approval process. Generated from their business information

Managed Clinical Solutions is located in New York. The company is a wholly-owned subsidiary of ICON Clinical Research. ICON is a global company with world headquarters in Dublin, Ireland. The United States headquarters is based in New Haven, Pa., near Philadelphia. ICON Clinical Research is a full-service clinical research organization that provides a comprehensive range of clinical services in Phase I-IV clinical trials to the pharmaceutical, biotechnology and device industries. With more than 35 operations in nearly 25 countries throughout the world, ICON has the infrastructure to take on global mega-trial. The company has conducted more than 800 studies that involved 250,000-plus patients in an excess of 12,000 centers all over the world.